[Research advance on non-small cell lung carcinoma with neuroendocrine differentiation].
作者信息
Dai Yun, Han Baohui
机构信息
Department of Respiratory Medicine, Shanghai Wujiaochang Hospital, Shanghai 200438, China.
出版信息
Zhongguo Fei Ai Za Zhi. 2011 Feb;14(2):165-9. doi: 10.3779/j.issn.1009-3419.2011.02.11.
Abstract
摘要
相似文献
1
[Research advance on non-small cell lung carcinoma with neuroendocrine differentiation].
Zhongguo Fei Ai Za Zhi. 2011 Feb;14(2):165-9. doi: 10.3779/j.issn.1009-3419.2011.02.11.
2
Genetic alterations in combined neuroendocrine neoplasms of the lung.
Mod Pathol. 2008 Apr;21(4):414-22. doi: 10.1038/modpathol.3801014. Epub 2008 Jan 18.
3
[Diagnosis of lung biopsy employing the 2015 WHO criteria and detection of related oncogenic driver mutations].
Zhonghua Bing Li Xue Za Zhi. 2019 Apr 8;48(4):270-275. doi: 10.3760/cma.j.issn.0529-5807.2019.04.002.
4
[Neuroendocrine lung tumors].
Ann Pathol. 1993;13(6):414-21.
5
[Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
Zhonghua Bing Li Xue Za Zhi. 2018 Jun 8;47(6):432-437. doi: 10.3760/cma.j.issn.0529-5807.2018.06.009.
6
Defining genomic alteration boundaries for a combined small cell and non-small cell lung carcinoma.
J Thorac Oncol. 2009 Feb;4(2):227-39. doi: 10.1097/JTO.0b013e3181952678.
7
High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.
J Surg Oncol. 2010 Jul 1;102(1):11-7. doi: 10.1002/jso.21576.
8
The value of immunohistochemical identification of neuroendocrine differentiation in non small cell lung carcinoma.
Rocz Akad Med Bialymst. 1997;42 Suppl 1:23-7.
9
EGFR mutation genotyping and ALK status determination in liquid-based cytology samples of non-small cell lung cancer.
Virchows Arch. 2020 May;476(5):753-762. doi: 10.1007/s00428-019-02692-9. Epub 2019 Dec 10.
10
Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis.
Appl Immunohistochem Mol Morphol. 2000 Mar;8(1):49-56.
引用本文的文献
1
Gene mutation, clinical characteristics and pathology in resectable lung adenocarcinoma.
World J Surg Oncol. 2025 Jan 22;23(1):16. doi: 10.1186/s12957-025-03680-x.
本文引用的文献
1
[Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Pneumonol Alergol Pol. 2010;78(1):33-46.
2
Prognostic factors in histopathology of lung cancer.
Front Radiat Ther Oncol. 2010;42:1-14. doi: 10.1159/000262457. Epub 2009 Nov 24.
3
Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: a review of published data.
Crit Rev Oncol Hematol. 2010 Aug;75(2):94-109. doi: 10.1016/j.critrevonc.2009.10.002. Epub 2009 Nov 13.
4
Lung tumours with neuroendocrine differentiation.
Eur J Cancer. 2009 Sep;45 Suppl 1:251-66. doi: 10.1016/S0959-8049(09)70040-1.
5
[Neuroendocrine tumours of the alimentary tract--history and at present].
Cesk Patol. 2009 Jul;45(3):57-63.
6
Molecular analysis of the HuD gene in neuroendocrine lung cancers.
Lung Cancer. 2010 Jan;67(1):69-75. doi: 10.1016/j.lungcan.2009.03.022.
7
Pathology of neuroendocrine tumours.
Front Biosci (Landmark Ed). 2009 Jan 1;14(12):4712-8. doi: 10.2741/3562.
8
Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer.
Cancer Res. 2008 Mar 15;68(6):1647-55. doi: 10.1158/0008-5472.CAN-07-5039.
9
Neuroendocrine tumors of the lung.
Curr Opin Oncol. 2008 Mar;20(2):148-54. doi: 10.1097/CCO.0b013e3282f35ed3.
10
Genetic alterations in combined neuroendocrine neoplasms of the lung.
Mod Pathol. 2008 Apr;21(4):414-22. doi: 10.1038/modpathol.3801014. Epub 2008 Jan 18.
Zotero 插件